. Author manuscript; available in PMC: 2020 Mar 9.

Published in final edited form as: Prostate. 2017 Mar 1;77(7):749–764. doi: 10.1002/pros.23311

TABLE I.

Basic Characteristics of the Newly Developed mAbs

mAb	Isotype	Epitope	Residues^a	Species^b	Experimental use^c
1A11	IgG1/κ	Linear	271–288	Human	WB, ICC, IHC, ELISA
3F11	IgG1/κ	Linear	226–243	Human, mouse, rat, pig, dog	WB, ICC, IHC, ELISA
5B1	IgG1/κ	Conformational	n.d.	Human	IF, ICC, IHC, ELISA, FC, in vivo
5D3	IgG1/κ	Conformational	n.d.	Human	IF, ICC, IHC, ELISA, FC, in vivo

Residues of human PSMA recognized by a given mAb.

PSMA orthologs recognized by a given mAb.

WB, Western blotting; ELISA, enzyme-linked immunosorbent assay; IHC, immunohistochemistry; ICC, immunocytochemistry; FC, flow cytometry; IF, immunofluorescence.